Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BridgeBio Pharma (BBIO) Non Operating Income: 2017-2024

Historic Non Operating Income for BridgeBio Pharma (BBIO) over the last 8 years, with Dec 2024 value amounting to $50.8 million.

  • BridgeBio Pharma's Non Operating Income fell 250.14% to -$41.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$194.1 million, marking a year-over-year decrease of 297.92%. This contributed to the annual value of $50.8 million for FY2024, which is 210.68% up from last year.
  • Per BridgeBio Pharma's latest filing, its Non Operating Income stood at $50.8 million for FY2024, which was up 210.68% from -$45.9 million recorded in FY2023.
  • In the past 5 years, BridgeBio Pharma's Non Operating Income registered a high of $50.8 million during FY2024, and its lowest value of -$45.9 million during FY2023.
  • Its 3-year average for Non Operating Income is $10.8 million, with a median of $27.6 million in 2022.
  • Per our database at Business Quant, BridgeBio Pharma's Non Operating Income surged by 215.54% in 2021 and then tumbled by 266.54% in 2023.
  • Yearly analysis of 5 years shows BridgeBio Pharma's Non Operating Income stood at -$31.0 million in 2020, then surged by 215.54% to $35.8 million in 2021, then declined by 23.09% to $27.6 million in 2022, then tumbled by 266.54% to -$45.9 million in 2023, then soared by 210.68% to $50.8 million in 2024.